SASCRO Statement on Prostate Radioactive Ligand Therapy
Prostate Radioactive Ligand Therapy should not be administered to patients outside ethically approved and formal clinical trials.
Prostate Radioactive Ligand Therapy should not be administered to patients outside ethically approved and formal clinical trials.